Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection

Journal of Clinical Endocrinology and Metabolism

Volumn 77, Issue 4, 1993, Pages 956-962

  Mulligan, Kathleen ^a,c,d   Grunfeld, Carl ^b,c   Hellerstein, Marc K ^a,c,d   Neese, Richard A ^c,d   Schambelan, Morris ^a,c  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN GROWTH HORMONE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; HORMONE ACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNER CELL MASS; MALE; NITROGEN BALANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; WEIGHT REDUCTION;

ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; EMACIATION; ENERGY METABOLISM; GROWTH HORMONE; HIV INFECTIONS; HUMAN; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MALE; NITROGEN; OXIDATION-REDUCTION; POTASSIUM; RECOMBINANT PROTEINS; SODIUM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; UREA; WEIGHT LOSS;

EID: 0027452211     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.77.4.8408471     Document Type: Article

References (40)

1. Kotier DP, Tierney AR, Wang J, Pierson Jr RN. 1989 Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 50:444-447.
2. Kotier DP, Wang J, Pierson Jr RN. 1985 Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr. 42:1255-1265.
3. Brozek J, Wells S, Keys A. 1946 Medical aspects of semistarvation in Leningrad (siege 1941-1942). Am Rev Soviet Med. 4:70-86.
4. Kotier DP, Tierney AR, Culpepper-Morgan JA, Wang J, Pierson Jr RN. 1990 Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. JPEN. 14:454-458.
5. Hellerstein MK, Kahn J, Mudie H, Viteri F. 1990 Current approach to the treatment of human immunodeficiency virus-associated weight loss: pathophysiologic considerations and emerging management strategies. Semin Oncol. 17(Suppl 9):17-33.
6. Grunfeld C, Feingold KR. 1992 Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med. 327:329-337.
7. Bengtsson B-A, Eden S, Lonn L, et al. 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 76:309-317.
8. Rudman D, Feller AG, Nagraj HS, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
9. Manson JMcK, Wilmore DW. 1986 Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery. 100:188-197.
10. Snyder DK, Clemmons DR, Underwood LE. 1988 Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition. J Clin Endocrinol Metab. 67:54-61.
11. Tayek JA, Brasel JA. 1992 Growth hormone administration decreases urea nitrogen losses in malnourished cancer patients. [Abstract] Clin Res. 40:95A.
12. Ward HC, Halliday D, Sim AJW. 1987 Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Arm Surg. 206:56-61.
13. Ziegler TR, Young LS, Ferrari-Baliviera E, Demling RH, Wilmore DW. 1990 Use of human growth hormone combined with nutritional support in a critical care unit. JPEN. 14:574-581.
14. Society of Actuaries, Association of Life Insurance Medical Directors of America. 1989-1979 Build Study. New York: Metropolitan Life Insurance; p 127.
15. Harris J, Benedict F. 1919 A biometric study of basal metabolism in man. Washington, DC: Carnegie Institution Publication 279.
16. Ferrannini E. 1988 The theoretical bases of indirect calorimetry: a review. Metabolism. 3:287-301.
17. Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB. 1988 Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr. 47:714.
18. Kushner RF, SchoeUer DA, Fjeld CR, Danford L. 1992 Is the impedance index (htVR) significant in predicting total body water? Am J Clin Nutr. 56:835-839.
19. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. 1992 Lipids, lipoproteins, triglyceride clearance, and cy-tokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 74:1045-1052.
20. Wolfe RR. 1984 Tracers in metabolic research. Radioisotope and stable isotope/mass spectrometry methods. New York: Alan R. Liss.
21. Hellerstein MK, Christiansen M, Kaempfer S, et al. 1991 Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest. 87:1841-1852.
22. 2, pH, and lactate from arterialized venous blood. J Appl Physiol. 32:134-137.
23. Mayes D, Furuyama S, Kem DC, Nugent CA. 1970 A radioimmunoassay for plasma aldosterone. J Clin Endocrinol Metab. 30:682-685.
24. Stockigt JR, Collins RD, Noakes CA, Schambelan M. 1972 Renal-vein renin in various forms of renal hypertension. Lancet. 1:1194-1197.
25. Beylot M, Martin C, Beaufrere B, Riou JP, Mornex R. 1987 Determination of steady-state and non steady-state glycerol kinetics in humans using deuterium-labeled tracer. J Lipid Res. 28:414-422.
26. Wiecko J, Sherman WR. 1976 Boroacetylation of carbohydrate. Correlations between structure and mass spectral behavior in mon-oacetylhexose cyclic boronic esters. J Am Chem Soc. 98:7631-7637.
27. Hellerstein MK. 1991 Relationship between precursor enrichment and ratio of excess M2/excess Ml isotopomer frequencies in a secreted polymer. J Biol Chem. 266:10920-10924.
28. Forbes GB. 1988 Body composition: influence of nutrition, disease, growth and aging. In: Shils ME, Young VR, eds. Modem nutrition in health and disease. 7th ed. Philadelphia: Lea & Febiger; pp 533-556.
29. Krentz AJ, Koster FT, Crist DM, et al. 1993 Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J Acquir Immune Defic Syndr. 6:245-251.
30. Farber SJ, Schubert M. 1957 The binding of cations by chondroitin sulfate. J Clin Invest. 36:1715-1722.
31. Hellerstein MK, Grunfeld C, Wu K, et al. 1992 Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab. 76:559-565.
32. Waterhouse C, Jeanpretre N, Keilson J. 1979 Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res. 39:1968-1972.
33. Hommes MJT, Romijn JA, Endert E, Eeftinck-Schattenkerk JKM, Sauerwein HP. 1991 Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism. 40:651-656.
34. D'Ercole AJ, Stiles AD, Underwood LE. 1984 Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sri USA. 81:935-939.
35. Klein S, Wolfe RR. 1990 Whole-body lipolysis and triglyceride-fatty arid cycling in cachectic patients with esophageal cancer. J Clin Invest. 86:1403-1408.
36. Flatt J-P. 1979 The biochemistry of energy expenditure. In: Bray GA, ed. Recent advances in obesity research, vol II. Westport, CT: Technomic Publishing Co, Inc.; pp 211-228.
37. Fong Y, Rosenbaum M, Tracey KJ, et al. 1989 Recombinant growth hormone enhances muscle myosin heavy-chain mRNA accumulation and amino arid accrual in humans. Proc Natl Acad Sri USA. 86:3371-3374.
38. Fryburg DA, Gelfand RA, Barrett EJ. 1991 Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol. 260:E499-504.
39. Roberts SB, Young VR. 1988 Energy costs of fat and protein deposition in the human infant. Am J Clin Nutr. 48:951-955.
40. Zurlo F, Larson K, Bogardus C, Ravussin E. 1990 Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest. 86:1423-1427.